Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients

BACKGROUND: The role of dose escalation in patients receiving long-term androgen deprivation therapy (ADT) is still a controversial issue. The aim of the current study was to evaluate whether dose escalation for ≥76–80 Gy had any advantage in terms of biochemical disease-free survival (BDFS), distan...

Descripción completa

Detalles Bibliográficos
Autores principales: Daoud, Mohamed A, Aboelnaga, Engy M, Alashry, Mohamed S, Fathy, Salwa, Aletreby, Mostafa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644603/
https://www.ncbi.nlm.nih.gov/pubmed/29066917
http://dx.doi.org/10.2147/OTT.S141224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644603/
https://www.ncbi.nlm.nih.gov/pubmed/29066917
http://dx.doi.org/10.2147/OTT.S141224

Ejemplares similares